First, I need to recall the medications she received. The chemotherapy regimen was cyclophosphamide, doxorubicin, and fluorouracil. Doxorubicin is known for its cardiotoxic effects. Long-term use can lead to cardiomyopathy, which presents as heart failure symptoms.
The symptoms she's experiencing—exertional dyspnea, peripheral edema, and morning eye swelling (which could be related to fluid retention) are classic for heart failure. The physical exam findings of S3 gallop and bilateral rales (crackles) in the lungs suggest pulmonary congestion, which is seen in left-sided heart failure. The elevated blood pressure might contribute, but the primary issue here is likely the cardiotoxicity from doxorubicin.
Looking at the options, if the correct answer is cardiomyopathy due to doxorubicin, then the other options might be other causes. Let's think about possible distractors. Common causes of heart failure include hypertension, ischemic heart disease, valvular disease, or other chemotherapeutic agents. But given her history, doxorubicin is a top consideration.
Other options might include hypertension as a cause, but she has a history of cancer treatment which is a more direct cause. Alternatively, maybe another chemotherapy drug, but among the listed ones, doxorubicin is the cardiotoxic one. Cyclophosphamide can cause hemorrhagic cystitis, not cardiotoxicity. Fluorouracil's main side effects are gastrointestinal and myelosuppression. So the most likely answer is cardiomyopathy from doxorubicin.
The clinical pearl here is that doxorubicin has a known dose-dependent cardiotoxicity, and patients should be monitored for heart failure, especially with cumulative doses. The S3 gallop is a key sign of heart failure, and the presence of bilateral rales indicates pulmonary congestion. The morning eye swelling might be due to fluid retention from heart failure, not necessarily nephrotic syndrome unless there's another cause, but in this context, it's more likely related to heart failure.
**Core Concept**
The question assesses knowledge of **chemotherapy-induced cardiotoxicity**, specifically **doxorubicin-induced cardiomyopathy**, a well-documented complication of anthracycline-based regimens. Key signs include heart failure symptoms and an S3 gallop, reflecting ventricular dysfunction.
**Why the Correct Answer is Right**
Doxorubicin, an anthracycline, causes dose-dependent cardiotoxicity via oxidative stress and mitochondrial damage. The patient’s symptoms (exertional dyspnea, leg swelling, pulmonary crackles) and signs (S3 gallop, elevated BP) align with **left-sided heart failure**. The S3 gallop indicates ventricular volume overload, while bilateral rales suggest pulmonary congestion. Morning periorbital edema may reflect systemic fluid retention. Her history of doxorubicin use (part of the CMF regimen) directly links to
Free Medical MCQs · NEET PG · USMLE · AIIMS
Access thousands of free MCQs, ebooks and daily exams.
By signing in you agree to our Privacy Policy.